Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Japfa Comfeed Indonesia Tbk. (JPFA) vs Brigit Biofarmaka Teknologi Tbk. (OBAT)

Japfa Comfeed Indonesia Tbk.Trading
Brigit Biofarmaka Teknologi Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Japfa Comfeed Indonesia Tbk. dan Brigit Biofarmaka Teknologi Tbk.: Japfa Comfeed Indonesia Tbk. diperdagangkan di Rp2.030 (kapitalisasi pasar 23,8 T, volume 24 jam 8,44 jt), sedangkan Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp248 (kapitalisasi pasar 167,37 M, volume 24 jam 96,7 rb). Perbedaan utamanya: Japfa Comfeed Indonesia Tbk. jauh lebih besar — sekitar 142,2× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan Japfa Comfeed Indonesia Tbk. lebih aktif diperdagangkan (8,44 jt vs 96,7 rb). Mana yang lebih baik tergantung tujuan investasimu.

JPFAOBAT
Kapitalisasi Pasar
23,8 T167,37 M
Volume
8,44 jt96,7 rb
Lot
84,36 rb967
Perputaran
17,08 M23,82 jt
Harga Rata-rata
2.024,41246,34
Nilai Transaksi
17,08 M23,82 jt
Harga Ekuilibrium Indikatif
2.030248
Volume Ekuilibrium Indikatif
3,58 rb41

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

JPFA
Lihat detail
OBAT
Lihat detail

Tentang Japfa Comfeed Indonesia Tbk.

PT Japfa Comfeed Indonesia Tbk (the Company) was established within the framework of the Foreign Capital Investment Law No. 1 year 1967 based on Notarial Deed No. 59 dated January 18, 1971 of Djojo Muljadi, S.H., public notary, as amended by Notarial Deed No. 60 dated Februari 15, 1972, of the same notary. Japfa is currently the second largest animal feed producer in Indonesia with an estimated market share of around 35% in the domestic poultry feed market. The company was originally involved in the production of copra extraction pellets

Selengkapnya di halaman JPFA

Tentang Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Selengkapnya di halaman OBAT